Dr. Hyunwoo Shin, CEO

• BS, MS/PhD degrees at POSTECH

• Management Leadership:  Serial entrepreneur with proven track record in biotech startups, successfully leading ventures to multi-million dollar valuations

• Scientific Impact: Author of multiple peer-reviewed publications in nanomedicine and holder of 21 patents in medical nanoparticle innovations

• Principal investigator:  Secured and managed $4M in national research grants as Principal Investigator

• Commercialization of patents: Successfully commercialized two patented technologies through venture-backed startups

• R&D experience:  Lead pre-clinical studies in multiple therapeutic areas including ophthalmology and nephrology

• Large-scale manufacturing: established GMP compliant  nano-material medicines for submission to KFDA